Review
Managing newly diagnosed thyroid cancer
Anna M. Sawka, James D. Brierley, Shereen Ezzat and David P. Goldstein
CMAJ March 04, 2014 186 (4) 269-275; DOI: https://doi.org/10.1503/cmaj.121742
Anna M. Sawka
Division of Endocrinology (Sawka), Department of Medicine, University Health Network and University of Toronto; Department of Radiation Oncology (Brierley), University Health Network and University of Toronto; Endocrine Oncology Site Group (Ezzat), Princess Margaret Hospital; Department of Otolaryngology (Goldstein), University Health Network and University of Toronto, Ont.
MD PhDJames D. Brierley
Division of Endocrinology (Sawka), Department of Medicine, University Health Network and University of Toronto; Department of Radiation Oncology (Brierley), University Health Network and University of Toronto; Endocrine Oncology Site Group (Ezzat), Princess Margaret Hospital; Department of Otolaryngology (Goldstein), University Health Network and University of Toronto, Ont.
MDShereen Ezzat
Division of Endocrinology (Sawka), Department of Medicine, University Health Network and University of Toronto; Department of Radiation Oncology (Brierley), University Health Network and University of Toronto; Endocrine Oncology Site Group (Ezzat), Princess Margaret Hospital; Department of Otolaryngology (Goldstein), University Health Network and University of Toronto, Ont.
MDDavid P. Goldstein
Division of Endocrinology (Sawka), Department of Medicine, University Health Network and University of Toronto; Department of Radiation Oncology (Brierley), University Health Network and University of Toronto; Endocrine Oncology Site Group (Ezzat), Princess Margaret Hospital; Department of Otolaryngology (Goldstein), University Health Network and University of Toronto, Ont.
MD MScArticle Figures & Tables
Tables
In this issue
Article tools
Respond to this article
Managing newly diagnosed thyroid cancer
Anna M. Sawka, James D. Brierley, Shereen Ezzat, David P. Goldstein
CMAJ Mar 2014, 186 (4) 269-275; DOI: 10.1503/cmaj.121742
Jump to section
- Article
- How is disease-related risk of papillary thyroid cancer evaluated?
- What primary surgery is favoured in the management of this disease?
- What role can radioactive iodine or radiotherapy play after surgery?
- What is the role for long-term TSH suppression after surgery?
- Conclusion
- Acknowledgments
- Footnotes
- References
- Figures & Tables
- Related Content
- Responses
- Metrics